EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -0.5774
March 31, 2026 -0.3786
December 31, 2025 -0.7158
September 30, 2025 -0.4485
June 30, 2025 -0.2985
March 31, 2025 -1.782
December 31, 2024 -0.0999
Date Value
September 30, 2024 -0.1219
March 31, 2024 -0.1775
December 31, 2023 -0.2728
September 30, 2023 -0.1593
December 31, 2022 -0.0473
September 30, 2022 -0.0334

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
Arvinas, Inc. -0.8242
Fulcrum Therapeutics, Inc. -0.3433
Definium Therapeutics, Inc. -1.436

EPS Diluted (Quarterly) Related Metrics